Literature DB >> 9794869

"A calculated risk": the Salk polio vaccine field trials of 1954.

M Meldrum1.   

Abstract

Keywords:  Biomedical and Behavioral Research; Health Care and Public Health; National Foundation for Infantile Paralysis; Twentieth Century

Mesh：

Substances：

Year:  1998        PMID： 9794869      PMCID： PMC1114166          DOI： 10.1136/bmj.317.7167.1233

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  An evaluation of the 1954 poliomyelitis vaccine trials.

Authors:  T FRANCIS; R F KORNS; R B VOIGHT; M BOISEN; F M HEMPHILL; J A NAPIER; E TOLCHINSKY
Journal:  Am J Public Health Nations Health       Date:  1955-05

2.  Some recent advances in the study of poliomyelitis.

Authors:  J F ENDERS
Journal:  Medicine (Baltimore)       Date:  1954-05       Impact factor: 1.889

3.  Patenting the Sun. Polio and the Salk Vaccine. Jane S. Smith. Morrow, New York, 1990. 413 pp. + plates. $22.95.

Authors:  P M Mazumdar
Journal:  Science       Date:  1990-11-09       Impact factor: 47.728
  3 in total
  10 in total

Review 1.  Randomised controlled trials in cardiovascular medicine: past achievements, future challenges.

Authors:  S Yusuf
Journal:  BMJ       Date:  1999-08-28

2.  Real-World Evidence Should Be Used in Regulatory Decisions About New Pharmaceutical and Medical Device Products for Diabetes.

Authors:  David C Klonoff; Alberto Gutierrez; Alexander Fleming; David Kerr
Journal:  J Diabetes Sci Technol       Date:  2019-04-03

Review 3.  The moral justification for a compulsory human papillomavirus vaccination program.

Authors:  Joseph E Balog
Journal:  Am J Public Health       Date:  2009-02-05       Impact factor: 9.308

4.  Contemporary Medical Students' Perceptions of the Hippocratic Oath.

Authors:  Fritz Baumgartner; Gabriel Flores
Journal:  Linacre Q       Date:  2018-03-28

Review 5.  Is it better to consent to an RCT or to care? Muetadeltaepsilonnu alphagammaalphanu ("nothing in excess").

Authors:  Didier Dreyfuss
Journal:  Intensive Care Med       Date:  2004-12-17       Impact factor: 17.440

6.  Inhibition of viral RNA-dependent RNA polymerases with clinically relevant nucleotide analogs.

Authors:  Kieran Maheden; Brendan Todd; Calvin J Gordon; Egor P Tchesnokov; Matthias Götte
Journal:  Enzymes       Date:  2021-10-15

7.  Harnessing Natural Mosaics: Antibody-Instructed, Multi-Envelope HIV-1 Vaccine Design.

Authors:  Robert E Sealy; Barry Dayton; David Finkelstein; Julia L Hurwitz
Journal:  Viruses       Date:  2021-05-11       Impact factor: 5.048

8.  Suppression of established hepatocarcinoma in adjuvant only immunotherapy: alum triggers anti-tumor CD8+ T cell response.

Authors:  Bo Wang; Xuanyi Wang; Yumei Wen; Jing Fu; Hongyang Wang; Zhangmei Ma; Yan Shi; Bin Wang
Journal:  Sci Rep       Date:  2015-12-09       Impact factor: 4.379

9.  How Basic Immunological Principles May Instruct the Design of a Successful HIV-Type 1 Vaccine.

Authors:  Karen S Slobod; Julia L Hurwitz
Journal:  Viral Immunol       Date:  2020-04       Impact factor: 2.257

Review 10.  Trial designs using real-world data: The changing landscape of the regulatory approval process.

Authors:  Elodie Baumfeld Andre; Robert Reynolds; Patrick Caubel; Laurent Azoulay; Nancy A Dreyer
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-12-10       Impact factor: 2.890
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.